# Intellia Therapeutics, Inc.: Form DEF 14A, filed Apr 30, 2025

- Company: [Intellia Therapeutics, Inc.](/companies/ntla.md) (CIK 1652130)
- Form: DEF 14A
- Filed: 2025-04-30
- Accepted by EDGAR: Apr 30, 2025, 16:04 ET
- Period: 2025-06-11
- Accession: 0000950170-25-061023
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1652130/000095017025061023/ntla-20250430.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1652130/000095017025061023/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1652130/000095017025061023/ntla-20250430.htm

Filed Apr 30, 2025.
Source: SEC EDGAR, the filing index for accession 0000950170-25-061023. Last ingested by Listed: Nov 3, 2026, 19:46 ET. No prices; not investment advice.